In September 2013, the FDA unveiled new labeling recommendations for extended performing and prolonged release opioids requiring companies to eliminate average ache as sign to be used, in its place stating the drug is for "pain extreme plenty of to demand day-to-day, all-around-the-clock, long run opioid cure".Quite often, insurance providers will